172 results on '"Towne, Jennifer E."'
Search Results
2. Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation
3. Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model
4. Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease
5. Aquaporin 5-Deficient Mouse Lungs are Hyperresponsive to Cholinergic Stimulation
6. Identification of small-molecule protein–protein interaction inhibitors for NKG2D
7. Supplementary Figure 3 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
8. Supplementary Figure Legends from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
9. Data from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
10. Supplementary Figure 2 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
11. Supplementary Figure 4 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
12. Supplementary Methods, Figure Legends 1-2 from Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
13. Supplementary Figure 4 from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
14. Supplementary Figure 2 from Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
15. Supplementary Figure 1 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
16. Supplementary Figure 1 from Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
17. Supplementary Figure 9 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
18. Supplementary Figure 2 from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
19. Supplementary Figure 3 from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
20. Supplementary Figure 5 from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
21. Data from Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
22. Supplementary Methods from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
23. Supplementary Figure 5 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
24. Data from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
25. Supplementary Figure 7 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
26. Supplementary Figure 6 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
27. Supplementary Figure 8 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
28. Supplementary Figure 1 from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
29. Supplementary Methods from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
30. IL-36: An Epithelial Cytokine Important in Psoriasis
31. Get the IL-17F outta here!
32. Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions
33. Regulation and function of interleukin‐36 cytokines
34. Publisher Correction: Get the IL-17F outta here!
35. Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
36. IL-36: An Epithelial Cytokine Important in Psoriasis
37. QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis
38. IL-36 induces inflammation and collagen deposition in the lung: 253
39. High-throughput SiRNA screen to identify novel signaling molecules in the IL-17RA signaling pathway: 213
40. Cloning and characterization of murine Aqp5: evidence for a conserved aquaporin gene cluster
41. Role of IL-17 family members in psoriasis: PS2-045
42. Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
43. The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis
44. IL-23, IL-17RA and IL-17A inhibition in an inducible psoriatic-like mouse model
45. Decreased Expression of Aquaporin (AQP)1 and AQP5 in Mouse Lung after Acute Viral Infection
46. A Role for IL-12 in IBD after All?
47. P066 INTESTINAL EPITHELIAL MICROVILLI ARE ABNORMAL IN CROHN’S DISEASE
48. P066 INTESTINAL EPITHELIAL MICROVILLI ARE ABNORMAL IN CROHN'S DISEASE
49. Regulation and function of interleukin-36 cytokines
50. Mutation inIL 36 RNimpairs the processing and regulatory function of the interleukin‐36‐receptor antagonist and is associated with DITRA syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.